Will an FDA crackdown curb access to cheaper GLP-1 weight-loss drugs?
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."
Watch CBS News
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."
It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local convenience store.
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
You may have seen ads about the pink salt diet with endorsements from celebrities and doctors. It turns out, some of those ads are deepfakes, and it happened to one local doctor. CBS News New York's Lisa Rozner has her story.
Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using GLP-1s.
The federal government just reached a settlement with one company after investigators say it used deceptive claims and fake reviews to trick customers.
The federal government just reached a settlement with one company after investigators say it used deceptive claims and fake reviews to trick customers. CBS News New York's Tim McNicholas reports.
More cardiologists are turning to a surprising tool to help patients with heart health issues. Bradley Blackburn reports.
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread. CBS News New York's Lisa Rozner reports.
Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts is sharing new recommendations for how to use it.
Do weight loss drug labels warn enough about potential side effects? A patient who needed emergency surgery is suing prescription drugmaker Novo Nordisk.
Prosecutors say Isis Navarro Reyes posted social media videos marketing drugs that appeared to be Ozempic, Mesofrance and Axcion.
The disease is associated with more than 200 different health conditions, but treatments are often not covered by insurance.
GLP-1 class medications reduce cardiovascular risk and treat diabetes. But they also allow people to lose an average of 10-20 percent of their body weight in the first year. What does that mean for the overweight or obese?
Gyms are packed this time of year, but they don't stay that way as people slowly ditch their resolutions. We hear from Lee Lawrence, from Life Time Fitness, with some ways to help change that.
How do you know what weight loss method is right for you, and what is the safest way to get it accomplished? We ask the director of the Center for Weight Loss and Metabolic Health at Hackensack University Medical Center for his advice.
From the Ozempic "ripple effect" to health tech and more, experts share their predictions for 2024 wellness trends.
The medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.
Experts say the drugs can slow digestion so much that it puts patients at increased risk for a problem called pulmonary aspiration, which can cause dangerous lung damage, infections and even death.
A personal injury law firm filed a suit against Novo Nordisk and Eli Lilly and Co., the manufacturers of Ozempic and Mounjaro.
Shedding pounds isn't the only change patients might experience.
One estimate finds almost 42% of Americans are considered obese. So should weight issues be treated with medication, like any other disease?
